{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:42:34Z","timestamp":1771630954616,"version":"3.50.1"},"reference-count":160,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ncl.2020.07.006","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T18:13:41Z","timestamp":1602180821000},"page":"799-824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Toxin-Induced Subacute Encephalopathy"],"prefix":"10.1016","volume":"38","author":[{"given":"David P.","family":"Lerner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksey","family":"Tadevosyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2020.07.006_bib1","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3109\/00099308109035067","article-title":"Epidemological study of encephalopathies following bismuth administration per os. Characteristics of intoxicated subjects: comparison with a control group","volume":"18","author":"Martin-Bouyer","year":"1981","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ncl.2020.07.006_bib2","series-title":"CRC, Handbook of chemistryand physics","author":"Weast","year":"1984"},{"key":"10.1016\/j.ncl.2020.07.006_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/NRL.0000000000000144","article-title":"Bismuth subgallate toxicity in the age of online supplement use","volume":"22","author":"Sampognaro","year":"2017","journal-title":"Neurologist"},{"key":"10.1016\/j.ncl.2020.07.006_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5770\/cgj.21.323","article-title":"Bismuth toxicity presenting as declining mobility and falls","volume":"21","author":"Hogan","year":"2018","journal-title":"Can Geriatr J"},{"key":"10.1016\/j.ncl.2020.07.006_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jnnp.44.1.1","article-title":"Toxic substances and the nervous system: the role of clinical observation","volume":"44","author":"Le Quesne","year":"1981","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2020.07.006_bib6","first-page":"1663","article-title":"Bismuth treatment and blood mismuth levels","volume":"53","author":"Hillemand","year":"1977","journal-title":"Sem Hop"},{"key":"10.1016\/j.ncl.2020.07.006_bib7","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1212\/WNL.43.6.1265","article-title":"Encephalopathy from abuse of bismuth subsalicylate (Pepto-Bismol)","volume":"43","author":"Jungreis","year":"1993","journal-title":"Neurol"},{"key":"10.1016\/j.ncl.2020.07.006_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4236\/ijcm.2012.31010","article-title":"Bismuth toxicity: a rare cause of neurological dysfunction","volume":"3","author":"Reynold","year":"2012","journal-title":"Int J Clin Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/0028-3886.198185","article-title":"Chronic encephalopathy with ataxia, myoclonus, and auditory neuropathy. A case of bismuth poisoning","volume":"65","author":"Siram","year":"2017","journal-title":"Neurol India"},{"key":"10.1016\/j.ncl.2020.07.006_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/jnnp.44.1.62","article-title":"Epileptic phenomena in bismuth toxic encephalopathy","volume":"44","author":"Buge","year":"1981","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2020.07.006_bib11","first-page":"696","article-title":"Significant elimination of bismuth by haemodilaysis with a new heavy metal chelating agent","volume":"10","author":"Stevens","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ncl.2020.07.006_bib12","first-page":"72","article-title":"The checkered history of lithium in medicine","volume":"22","author":"Strobusch","year":"1980","journal-title":"Pharm Hist"},{"key":"10.1016\/j.ncl.2020.07.006_bib13","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/15563650.2015.1102927","article-title":"Annual report of the american association of poison control centers national poison data system (NPDS): 32ndannual report","volume":"53","author":"Mowry","year":"2015","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ncl.2020.07.006_bib14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/bmj.1.6116.815","article-title":"\u201cSevere lithium toxicity with \u201cnormal serum concentrations","volume":"1","author":"Speirs","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.ncl.2020.07.006_bib15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5414\/CPP49336","article-title":"Fatal lithium toxicity with therapeutic levels-a case report","volume":"49","author":"Venkatarathnamma","year":"2011","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.ncl.2020.07.006_bib16","article-title":"Hemodialysis for lithium poisoning","author":"Lavonas","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ncl.2020.07.006_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.wnf.0000150871.52253.b7","article-title":"The syndrome of irreversible-lithium effectuated neurotoxicity","volume":"28","author":"Adityanjee","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.ncl.2020.07.006_bib18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0002-9343(76)90145-5","article-title":"The cardiovascular effects of lithium in man. A review of the literature","volume":"61","author":"Tilkian","year":"1976","journal-title":"Am J Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib19","first-page":"1109","article-title":"Lithium toxicity: The illusion of PTSD","volume":"5","author":"Kelley","year":"2017","journal-title":"Ann Psychiatry Ment Health"},{"key":"10.1016\/j.ncl.2020.07.006_bib20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0196-0644(05)81610-5","article-title":"Whole bowel irrigation as a treatment for acute lithium overdose","volume":"20","author":"Smith","year":"1991","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib21","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0196-0644(05)81893-1","article-title":"Effect of sodium polystyrene sulfonate on lithium bioavailability","volume":"21","author":"Belanger","year":"1992","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1600-0447.1990.tb05490.x","article-title":"Lithium toxicity: when is hemodialysis necessary?","volume":"81","author":"Hauger","year":"1990","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.ncl.2020.07.006_bib23","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/15563650.2016.1185110","article-title":"Lithium poisoning in the intensive care unit: predictive factors of severity and indications for extracorporeal toxin removal to improve outcome","volume":"54","author":"Vodovar","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.ncl.2020.07.006_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/ki.1980.117","article-title":"Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness","volume":"18","author":"Pierides","year":"1980","journal-title":"Kidney Int"},{"key":"10.1016\/j.ncl.2020.07.006_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ki.1995.19","article-title":"Mechanisms of aluminum-induced microcytosis: lessons from accidental aluminum intoxication","volume":"47","author":"Caramelo","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.ncl.2020.07.006_bib26","first-page":"164","article-title":"Epidemic aluminum intoxication in hemodialysis patients tracted to use of an aluminum pump","volume":"47","author":"Burwen","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.ncl.2020.07.006_bib27","doi-asserted-by":"crossref","first-page":"742","DOI":"10.5858\/arpa.2017-0049-OA","article-title":"Aluminum Toxicity: Evaluation of 16-Year Trend Among 14,919 Patients and 45,480 Results","volume":"142","author":"Schifman","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/ndt\/gfl569","article-title":"Drugs as a hidden source of aluminum for chronic renal patients","volume":"22","author":"Bohrer","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ncl.2020.07.006_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/B978-0-7020-4086-3.00025-4","article-title":"Nervous system disorders in dialysis patients","volume":"119","author":"Bansal","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.ncl.2020.07.006_bib30","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s10072-018-3426-y","article-title":"Advances in dialysis encepahlopathy research: a review","volume":"39","author":"Chen","year":"2018","journal-title":"Neurol Sci"},{"key":"10.1016\/j.ncl.2020.07.006_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJM197601222940402","article-title":"The dialysis encephalopathy syndrome - possible aluminum intoxication","volume":"294","author":"Alfrey","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM199102213240804","article-title":"Aluminum accuulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease","volume":"324","author":"Salusky","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0272-6386(12)80572-5","article-title":"Cerebrospinal fluid aluminum levels following deferoxamine","volume":"16","author":"Ellenberg","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ncl.2020.07.006_bib34","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1093\/ndt\/gfi072","article-title":"Dialysis encephalopathy secondary to aluminum toxicity diagnosed by bone biopsy","volume":"20","author":"Modelli Andrade","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ncl.2020.07.006_bib35","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ncl.2020.07.006_bib36","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(80)92728-2","article-title":"Successful removal of aluminum form patients with dialysis encephalopathy","volume":"2","author":"Ackrill","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2020.07.006_bib37","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1056\/NEJM199811263392206","article-title":"Carbon monoxide poisoning","volume":"339","author":"Ernst","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib38","first-page":"1768","article-title":"US mortality due to carbon monoxide poisoning, 1999-2014. accidental and intentional deaths","volume":"13","author":"Hampson","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ncl.2020.07.006_bib39","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1164\/rccm.201606-1275CI","article-title":"Carbon monoxide poisoning: pathogenesis, management and future directions of therapy","volume":"195","author":"Rose","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib40","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ajem.2004.02.011","article-title":"Carbon monoxide poisoning while using a small cooking stove in a tent","volume":"22","author":"Thomassen","year":"2004","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib41","first-page":"920","article-title":"Carbon monoxide poisoning attributed to underground utility cable fifers--New York. January 20000-June 2004","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ncl.2020.07.006_bib42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jemermed.2014.12.091","article-title":"Carbon monoxide poisoning from portable electrical generators","volume":"49","author":"Hampson","year":"2015","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s13181-017-0617-5","article-title":"Carbon monoxide poisoning from hookah smoking: an emerging public health problem","volume":"13","author":"Retzky","year":"2017","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.ncl.2020.07.006_bib44","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/15563659409017973","article-title":"Pathophysiology and treatment of carbon monoxide poisoning","volume":"32","author":"Hardy","year":"1994","journal-title":"J\u00a0Toxicol Clin Toxicol"},{"key":"10.1016\/j.ncl.2020.07.006_bib45","doi-asserted-by":"crossref","unstructured":"Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology 2008;55:310\u20138.","DOI":"10.1016\/j.neuropharm.2008.01.005"},{"key":"10.1016\/j.ncl.2020.07.006_bib46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2377-14-153","article-title":"Neuropsychological outcome after carbon monoxide exposure following a storm: a case-control study","volume":"14","author":"Pages","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ncl.2020.07.006_bib47","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1001\/jama.295.4.398","article-title":"Cardiovascular injury and long-term mortality following moderate to severe carbon monoxide poisoning","volume":"295","author":"Satran","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ncl.2020.07.006_bib48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/brainsci9110292","article-title":"Amantadine improves delayed neuropsychiatric sequelae of carbon monoxide poisoning: a case report","volume":"9","author":"Nakano","year":"2019","journal-title":"Brain Sci"},{"key":"10.1016\/j.ncl.2020.07.006_bib49","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1164\/rccm.201207-1284CI","article-title":"Practice recommendations in the diagnosis, management and prevention of carbon monoxide poisoning","volume":"186","author":"Hampson","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib50","doi-asserted-by":"crossref","first-page":"e2418","DOI":"10.1097\/MD.0000000000002418","article-title":"Patients with Carbon monoxide poisoning and subsequent dementia: a population-based cohort study","volume":"95","author":"Lia","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ncl.2020.07.006_bib51","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.200701-026OC","article-title":"Carbon monoxide poisoning: risk factors for cognitive sequelae and the role of hyperbaric oxygen","volume":"176","author":"Weaver","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib52","unstructured":"Hyperbaric recommendations: Undersea Hyperbaric Medical Society. Hyperbaric Oxygen Committee. Hyperbaric Oxygen Therapy Indications: The Hyperbaric Oxygen Therapy Committee Report. 2008."},{"key":"10.1016\/j.ncl.2020.07.006_bib53","first-page":"21","article-title":"Hyperbaric treatment of patients with carbon monoxide poisoning in the United States","volume":"32","author":"Hampson","year":"2005","journal-title":"Undersea Hyperb Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib54","doi-asserted-by":"crossref","first-page":"R264","DOI":"10.1186\/cc13094","article-title":"Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy","volume":"17","author":"Fugate","year":"2013","journal-title":"Crit Care"},{"issue":"suppl 2","key":"10.1016\/j.ncl.2020.07.006_bib55","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1086\/428055","article-title":"Antimicrobial safety: focus on fluoroquinolones","volume":"41","author":"Owens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ncl.2020.07.006_bib56","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.clinthera.2014.09.020","article-title":"Neurotoxicity with antimicrobials in the elderly: a review","volume":"36","author":"Mattappalil","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.ncl.2020.07.006_bib57","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2125.2011.03991.x","article-title":"Neurotoxic effects associated with antibiotic use: management considerations","volume":"72","author":"Grill","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ncl.2020.07.006_bib58","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1212\/WNL.0000000000002455","article-title":"Antibiotic-associated encephalopathy","volume":"86","author":"Bhattacharyya","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2020.07.006_bib59","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1345\/aph.1L307","article-title":"Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring","volume":"42","author":"Grill","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ncl.2020.07.006_bib60","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jac\/27.4.405","article-title":"Neurotoxicity of beta-lactam antibiotics: predisposing factors and pathogenesis","volume":"27","author":"Schliamser","year":"1991","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ncl.2020.07.006_bib61","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.21.7.759","article-title":"Penicillinase and the convulsant action of penicillin","volume":"21","author":"Gutnick","year":"1971","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2020.07.006_bib62","article-title":"Ceftaroline-associated encephalopathy in patient with severe renal impairment","author":"Martin","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ncl.2020.07.006_bib63","first-page":"72","article-title":"Ceftriaxone-induced acute reversible encephalopathy in a patient treated for a urinary tract infection","volume":"67","author":"Roncon-Albuquerque","year":"2009","journal-title":"Neth J Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib64","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0002-9343(88)90071-X","article-title":"Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem\/cilastatin","volume":"84","author":"Calandra","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijid.2003.09.003","article-title":"Cefepime-induced encephalopathy","volume":"8","author":"Dakdouki","year":"2004","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ncl.2020.07.006_bib66","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1046\/j.1528-1157.2001.34701.x","article-title":"Seizures in the critically ill: the role of imipenem","volume":"42","author":"Koppel","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.ncl.2020.07.006_bib67","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7164\/antibiotics.48.408","article-title":"Structural features resulting in convulsive activity of carbapenem compounds: effect of C-2 side chain","volume":"48","author":"Sunagawa","year":"1995","journal-title":"J\u00a0Antibiot"},{"key":"10.1016\/j.ncl.2020.07.006_bib68","first-page":"841","article-title":"Vestibulotoxicity following aminoglycoside antibiotics and its prevention","volume":"4","author":"Darlington","year":"2003","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.ncl.2020.07.006_bib69","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0006-8993(98)01123-8","article-title":"Aminoglycoside neurotoxicity involves NMDA receptor activation","volume":"815","author":"Segal","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.ncl.2020.07.006_bib70","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.2165\/00003495-198700341-00031","article-title":"Side effects of ofloxacin in clinical trials and in postmarketing surveillance","volume":"34","author":"Jungst","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.ncl.2020.07.006_bib71","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000239301","article-title":"Levofloxacin, an optical isomer of ofloxacin, has attenudated epileptogenic activity in mice and inhibitory potency in GABA receptor binding","volume":"40","author":"Akahane","year":"1994","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ncl.2020.07.006_bib72","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/106002809603000205","article-title":"Association of a Tourette-like syndrome with ofloxacin","volume":"30","author":"Thomas","year":"1996","journal-title":"Ann Pharmocother"},{"key":"10.1016\/j.ncl.2020.07.006_bib73","doi-asserted-by":"crossref","first-page":"142","DOI":"10.12968\/hosp.2000.61.2.2404","article-title":"Ciprofloxacin-induced oral-facial dyskinesia in a patient with normal liver and renal function","volume":"61","author":"Lee","year":"2000","journal-title":"Hosp Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib74","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7326\/0003-4819-101-1-92","article-title":"The neurotoxicity of antibacterial agents","volume":"101","author":"Snavely","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib75","doi-asserted-by":"crossref","first-page":"e739","DOI":"10.1542\/peds.2004-1352","article-title":"Transient psychosis in an immune-competent patient after oral trimethoprim-sulfamethoxazole administration","volume":"115","author":"Saidinejad","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ncl.2020.07.006_bib76","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.ijid.2008.03.006","article-title":"Cerebellar ataxia following prolonged use of metronidazole: case report and literature review","volume":"12","author":"Patel","year":"2008","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ncl.2020.07.006_bib77","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/WNF.0b013e3182334b35","article-title":"Metronidazole-induced central nervous system toxicity: a systematic review","volume":"34","author":"Kuriyama","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.ncl.2020.07.006_bib78","series-title":"Neurologic complications of cancer","first-page":"447","article-title":"Side effects of chemotherapy","author":"DeAngelis","year":"2009"},{"key":"10.1016\/j.ncl.2020.07.006_bib79","series-title":"Cancer neurology in clinical practice","first-page":"287","article-title":"Neurologic complications of chemotherapy","author":"Dietrich","year":"2008"},{"key":"10.1016\/j.ncl.2020.07.006_bib80","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2165\/00003495-200363150-00003","article-title":"Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management","volume":"63","author":"Verstappen","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.ncl.2020.07.006_bib81","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1200\/JCO.1986.4.12.1845","article-title":"Transient cerebral dysfunction secondary to high-dose methotrexate","volume":"4","author":"Walker","year":"1986","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ncl.2020.07.006_bib82","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0140-6736(72)93050-4","article-title":"Methotrexate meningitis","volume":"2","author":"Mott","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2020.07.006_bib83","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/annonc\/mdm466","article-title":"Clinical and radiological characteristcs of methotrexate-induced acute encephalopathy in pediatric patients with cancer","volume":"19","author":"Inaba","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ncl.2020.07.006_bib84","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2141.1992.tb08256.x","article-title":"Transient neurologic disturbances in a child treated with moderate-dose methotrexate","volume":"81","author":"Borgna-Pignatti","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ncl.2020.07.006_bib85","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1200\/JCO.2013.53.0808","article-title":"Methotrexate-induced neurotoxicity and leukocenphalopathy in childhood acute lymphoblastic leukemia","volume":"32","author":"Bhojwani","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ncl.2020.07.006_bib86","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/1097-0142(197502)35:2<291::AID-CNCR2820350202>3.0.CO;2-V","article-title":"Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma","volume":"35","author":"Rubinstein","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.ncl.2020.07.006_bib87","first-page":"127","article-title":"Neurotoxicities of current leukemia therapy","volume":"1","author":"Pizzo","year":"1979","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ncl.2020.07.006_bib88","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00234-003-0983-3","article-title":"MRI in methotrexate-related leukoencephalopathy: Disseminated necrotising leukoencephalopathy in comparison with mild leukoencephalopathy","volume":"45","author":"Oka","year":"2003","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ncl.2020.07.006_bib89","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/jnnp.47.1.65","article-title":"Necrotisin leukoencephalopathy complicating treatment of childhood leukaemia","volume":"47","author":"Robain","year":"1984","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2020.07.006_bib90","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1200\/JCO.1998.16.3.864","article-title":"High-dose methotrexate for the treatment of primary cerebral lymphoma: analysis of survival and late neurologic toxicity in a retrospective series","volume":"16","author":"Blay","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ncl.2020.07.006_bib91","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1200\/JCO.1997.15.2.833","article-title":"High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency","volume":"15","author":"Smith","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ncl.2020.07.006_bib92","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.leu.2402063","article-title":"Cytarabine-induced aseptic meningitis","volume":"15","author":"Ven den Berg","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.ncl.2020.07.006_bib93","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/1097-0142(19860315)57:6<1083::AID-CNCR2820570602>3.0.CO;2-B","article-title":"Progressive ascending paralysis following administration of intrathecal and intravenous cytosine arabinoside: a Pediatric Oncology Group Study","volume":"57","author":"Dunton","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.ncl.2020.07.006_bib94","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.14.10.961","article-title":"Acute cerebellar syndrome secondary to 5-fluorouracil therapy","volume":"14","author":"Riehl","year":"1964","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2020.07.006_bib95","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0140-6736(71)90877-4","article-title":"Cerebellar ataxia with weekly 5-fluorouracil administration","volume":"1","author":"Gottlieb","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2020.07.006_bib96","first-page":"477","article-title":"Severe neurotoxicity following 5-fluorouracil based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency","volume":"2","author":"Takimoto","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ncl.2020.07.006_bib97","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/1097-0142(19830115)51:2<220::AID-CNCR2820510209>3.0.CO;2-W","article-title":"Effect of allopurinol on the toxicity of high-dose 5-fluorouracil administered by intermittent bolus injection","volume":"51","author":"Howell","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.ncl.2020.07.006_bib98","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00001813-199903000-00004","article-title":"Risk of transient hyperammonemic encephalopathy in cancers patients who received continuous infusion of 5-fluorouracil with the complication of dehydration and infection","volume":"10","author":"Liaw","year":"1999","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ncl.2020.07.006_bib99","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/1097-0142(197907)44:1<69::AID-CNCR2820440113>3.0.CO;2-O","article-title":"Blurring of vision: a previously undescribed complication of cyclophosphamide therapy","volume":"44","author":"Kende","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.ncl.2020.07.006_bib100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.coc.0000158439.02724.5a","article-title":"Evaluating risk factors for the development of ifosfamide encepahlopathy","volume":"28","author":"David","year":"2005","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ncl.2020.07.006_bib101","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00001813-200404000-00006","article-title":"Incidence and severeity of ifosfamide-induced encephalopathy","volume":"15","author":"Rieger","year":"2004","journal-title":"Anitcancer Drugs"},{"key":"10.1016\/j.ncl.2020.07.006_bib102","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/1097-0142(19940301)73:5<1509::AID-CNCR2820730531>3.0.CO;2-G","article-title":"Hallucinations and ifosfamide-induced neurotoxicity","volume":"73","author":"DiMaggio","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ncl.2020.07.006_bib103","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1054\/bjoc.1999.0917","article-title":"Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature","volume":"82","author":"Pelgrims","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ncl.2020.07.006_bib104","first-page":"4636","article-title":"Treatment of ifosfamide encephalopathy with intravenous thiamine","volume":"9","author":"Buesa","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ncl.2020.07.006_bib105","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib106","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S1470-2045(18)30649-1","article-title":"Lorlatinib in patients with ALK-positive non-small cell lung cancer: results from a global phase 2 study","volume":"19","author":"Solomon","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ncl.2020.07.006_bib107","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1001\/archopht.1982.01030040746007","article-title":"Ocular toxicity associated with high-dose carmustine","volume":"100","author":"Shingleton","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ncl.2020.07.006_bib108","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1040-8428(98)00015-8","article-title":"Use of L-asparaginase in childhood ALL","volume":"28","author":"Muller","year":"1998","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ncl.2020.07.006_bib109","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/annonc\/mdl436","article-title":"Reversible posterior leukoencephalopathy syndrome after carboplatin therapy","volume":"18","author":"Vieillot","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ncl.2020.07.006_bib110","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bcp.12955","article-title":"Prescribing pattern of antipsychotic drugs during the years 1996\u20132010: a population based database study in Europe with a focus on torsadogenic drugs","volume":"82","author":"Oteri","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ncl.2020.07.006_bib111","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1089\/cap.2017.0077","article-title":"National patterns of commonly prescribed psychotropic medications to young people","volume":"28","author":"Sultan","year":"2018","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"2","key":"10.1016\/j.ncl.2020.07.006_bib112","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pds.2082","article-title":"Increasing off-label use of antipsychotic medications in the United State, 1995-2008","volume":"20","author":"Alexander","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.ncl.2020.07.006_bib113","first-page":"16","article-title":"Outpatient use of major antipsychotic drugs in ambulatory care settings in the United States, 1997-2000","volume":"5","author":"Van Brunt","year":"2003","journal-title":"Medscape Gen Med"},{"key":"10.1016\/j.ncl.2020.07.006_bib114","first-page":"1","article-title":"Antidepressant use in persons aged 12 and over: United States, 2005-2008","volume":"76","author":"Pratt","year":"2011","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ncl.2020.07.006_bib115","series-title":"Antidepressant use among persons aged 12 and over: United States, 2011\u20132014. NCHS data brief, no 283","author":"Pratt","year":"2017"},{"key":"10.1016\/j.ncl.2020.07.006_bib116","series-title":"Health at a glance 2015: OECD indicators OECD indicators","first-page":"217","author":"OECD","year":"2015"},{"issue":"3","key":"10.1016\/j.ncl.2020.07.006_bib117","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/1574886313666180605095130","article-title":"Adverse effects of antidepressants reported by a large international cohort: emotional blunting, suicidality, and withdrawal effects","volume":"13","author":"Read","year":"2018","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.ncl.2020.07.006_bib118","doi-asserted-by":"crossref","first-page":"e027663","DOI":"10.1136\/bmjopen-2018-027663","article-title":"Multinational comparison of new antidepressant use in older adults: a cohort study","volume":"9","author":"Tamblyn","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ncl.2020.07.006_bib119","doi-asserted-by":"crossref","first-page":"247486","DOI":"10.1155\/2013\/247486","article-title":"Risk of mortality (including sudden cardiac death) and major cardiovascular events in atypical and typical antipsychotic users: a study with the general practice research database","volume":"2013","author":"Murray-Thomas","year":"2013","journal-title":"Cardiovasc Psychiatry Neurol"},{"issue":"12","key":"10.1016\/j.ncl.2020.07.006_bib120","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/15563650.2018.1533727","article-title":"Clinical toxicology. 2017 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 35th annual report","volume":"56","author":"Gummin","year":"2018","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.ncl.2020.07.006_bib121","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annu Rev Med"},{"issue":"8","key":"10.1016\/j.ncl.2020.07.006_bib122","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A\u00a0review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.ncl.2020.07.006_bib123","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ncl.2020.07.006_bib124","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.3390\/ijms20092288","article-title":"The serotonin syndrome: from molecular mechanisms to clinical practice","volume":"20","author":"Francescangeli","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ncl.2020.07.006_bib125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12883-016-0616-1","article-title":"Conundrums in neurology: diagnosing serotonin syndrome \u2013 a meta-analysis of cases","volume":"16","author":"Werneke","year":"2016","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ncl.2020.07.006_bib126","first-page":"19","article-title":"An atypical case of serotonin syndrome with normal dose of selective serotonin inhibitors","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.ncl.2020.07.006_bib127","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12245-010-0195-7","article-title":"The serotonin syndrome-the need for physician's awareness","volume":"3","author":"Arora","year":"2010","journal-title":"Int J Emerg Med"},{"issue":"8","key":"10.1016\/j.ncl.2020.07.006_bib128","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jamaneurol.2013.95","article-title":"Serotonin syndrome associated with clozapine withdrawal","volume":"70","author":"Stevenson","year":"2013","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2020.07.006_bib129","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1345\/aph.10113","article-title":"Possible serotonin syndrome associated with clomipramine after withdrawal of clozapine","volume":"35","author":"Zerjav-Lacombe","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.ncl.2020.07.006_bib130","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/mds.10282","article-title":"Clozapine withdrawal symptoms in a Parkinson's disease patient","volume":"17","author":"Zesiewicz","year":"2002","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ncl.2020.07.006_bib131","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/15563650701285289","article-title":"Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management","volume":"45","author":"Nelson","year":"2007","journal-title":"Clin Toxicol"},{"issue":"11","key":"10.1016\/j.ncl.2020.07.006_bib132","first-page":"1439","article-title":"Serotonin syndrome: a brief review","volume":"168","author":"Birmes","year":"2003","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.ncl.2020.07.006_bib133","doi-asserted-by":"crossref","first-page":"604","DOI":"10.12659\/AJCR.909063","article-title":"Delayed serotonin syndrome in the setting of a mixed fluoxetine and serotonin antagonist overdose","volume":"19","author":"Little","year":"2018","journal-title":"Am J Case Rep"},{"issue":"1","key":"10.1016\/j.ncl.2020.07.006_bib134","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1526-4637.2003.03005.x","article-title":"Serotonin syndrome and other serotonergic disorders","volume":"4","author":"Ener","year":"2003","journal-title":"Pain Med"},{"issue":"9","key":"10.1016\/j.ncl.2020.07.006_bib135","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley","year":"2003","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.ncl.2020.07.006_bib136","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/0310057X0503300205","article-title":"Serotonin syndrome and the anaesthetist","volume":"33","author":"Jones","year":"2005","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.ncl.2020.07.006_bib137","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00002018-199819010-00006","article-title":"Neuroleptic malignant syndrome. Recognition, prevention and management","volume":"1","author":"Velamoor","year":"1998","journal-title":"Drug Saf"},{"issue":"10","key":"10.1016\/j.ncl.2020.07.006_bib138","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson","year":"1985","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2020.07.006_bib139","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","article-title":"Neuroleptic malignant syndrome","volume":"77","author":"Caroff","year":"1993","journal-title":"Med Clin North Am"},{"issue":"3","key":"10.1016\/j.ncl.2020.07.006_bib140","first-page":"79","article-title":"The neuroleptic malignant syndrome","volume":"41","author":"Caroff","year":"1980","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2020.07.006_bib141","first-page":"18","article-title":"Mortality from neuroleptic malignant syndrome","volume":"50","author":"Shalev","year":"1989","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.ncl.2020.07.006_bib142","first-page":"193","article-title":"Classification system of complications in neuroleptic malignant syndrome","volume":"19","author":"Taniguchi","year":"1997","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.ncl.2020.07.006_bib143","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/0006-3223(87)90010-2","article-title":"Neuroleptic malignant syndrome: review and analysis of 115 cases","volume":"22","author":"Addonizio","year":"1987","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2020.07.006_bib144","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12028-015-0162-5","article-title":"Neuroleptic malignant syndrome: complications, outcomes, and mortality","volume":"24","author":"Modi","year":"2016","journal-title":"Neurocrit Care"},{"issue":"4","key":"10.1016\/j.ncl.2020.07.006_bib145","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/JCP.0b013e31817ea9c1","article-title":"Neuroleptic malignant syndrome and the acute phase response","volume":"28","author":"Rosebush","year":"2008","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.ncl.2020.07.006_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-014-3807-8","article-title":"Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma","volume":"232","author":"Lang","year":"2015","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.ncl.2020.07.006_bib147","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4088\/JCP.10m06791","article-title":"Mortality of neuroleptic malignant syndrome induced by typical and atypical antipsychotic drugs: a propensity-matched analysis from the Japanese Diagnosis Procedure Combination database","volume":"73","author":"Nakamura","year":"2012","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2020.07.006_bib148","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1176\/appi.psy.50.1.8","article-title":"Neuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients: case reports and a review of the literature","volume":"50","author":"Seitz","year":"2009","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1016\/j.ncl.2020.07.006_bib149","first-page":"477","article-title":"Neuroleptic malignant syndrome and malignant hyperthermia","volume":"21","author":"Caroff","year":"1993","journal-title":"Anaesth Intensive Care"},{"issue":"4","key":"10.1016\/j.ncl.2020.07.006_bib150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/hup.483","article-title":"Olanzapine induced neuroleptic malignant syndrome--a case review","volume":"18","author":"Kogoj","year":"2003","journal-title":"Hum Psychopharmacol"},{"issue":"1","key":"10.1016\/j.ncl.2020.07.006_bib151","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40268-014-0078-0","article-title":"Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis","volume":"15","author":"Belvederi Murri","year":"2015","journal-title":"Drugs in R&D"},{"key":"10.1016\/j.ncl.2020.07.006_bib152","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.genhosppsych.2015.09.008","article-title":"Electroconvulsive therapy in the intensive care unit for the treatment of catatonia: a case series and review of the literature","volume":"38","author":"Dessens","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"issue":"19","key":"10.1016\/j.ncl.2020.07.006_bib153","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1001\/jama.1985.03360190098033","article-title":"A\u00a0neuroleptic malignant like syndrome due to levodopa therapy withdrawal","volume":"254","author":"Friedman","year":"1985","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ncl.2020.07.006_bib154","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1353-8020(02)00035-4","article-title":"Neuroleptic malignant syndrome-like, or--dopaminergic malignant syndrome--due to levodopa therapy withdrawal. Clinical features in 11 patients","volume":"9","author":"Serrano-Due\u00f1as","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"10.1016\/j.ncl.2020.07.006_bib155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0733-8627(05)70127-9","article-title":"The neuroleptic malignant and serotonin syndromes","volume":"18","author":"Carbone","year":"2000","journal-title":"Emerg Med Clin North Am"},{"issue":"3","key":"10.1016\/j.ncl.2020.07.006_bib156","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/WNF.0000000000000151","article-title":"Role of dexmedetomidine for sedation in neurocritical care patients: a qualitative systematic review and meta-analysis of current evidence","volume":"39","author":"Tsaousi","year":"2016","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"10.1016\/j.ncl.2020.07.006_bib157","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/187152411794961031","article-title":"Catatonia: a narrative review","volume":"11","author":"Fornaro","year":"2011","journal-title":"Cent Nerv Syst Agents Med Chem"},{"issue":"5","key":"10.1016\/j.ncl.2020.07.006_bib158","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/jnnp.74.5.574","article-title":"Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease","volume":"74","author":"Sato","year":"2003","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2020.07.006_bib159","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4088\/JCP.v65n0403","article-title":"Neuroleptic malignant syndrome and atypical antipsychotic drugs","volume":"65","author":"Ananth","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2020.07.006_bib160","first-page":"533","article-title":"Serotonin syndrome","volume":"13","author":"Volpi-Abadie","year":"2013","journal-title":"Ochsner J"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386192030058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386192030058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:17:35Z","timestamp":1760005055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386192030058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":160,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S073386192030058X"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2020.07.006","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxin-Induced Subacute Encephalopathy","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2020.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}